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UGLY
F. Edward Dudek∗, Tallie Z. Baram†, Edward H. Bertram‡ and
Frances E. Jensen§
∗Dept of Physiology, University of Utah School of Medicine, Salt
Lake City, UT; †Dept of Pediatrics, University of California
Irvine, Irvine, CA; ‡Dept of Neurology, University of Virginia,
Charlottesville, VA and §Dept of Neurology, Harvard Medical
School, Childrens HospitalUniversity of Virginia, Boston, MA
Summary: Acquired epilepsy is generally considered to be the time-
dependent development of spontaneous recurrent seizures after an insult 
to the brain. To monitor for and confirm the presence of bona fide seizures 
can be technically demanding and resource-intensive, particularly when 
one considers the time required for the development of chronic epilepsy 
after a brain insult and the effort necessary to detect and validate the ac-
tual seizures, which have a range of specific electrical properties and typ-
ically last 10’s of seconds to minutes. The use of alternatives to these ac-
tual seizures, or surrogate markers, for epileptogenesis has a long history, 
but is founded on several unproven assumptions. Examples of surrogate 
markers for experimental epilepsy include (1) “hyperexcitability” to ex-
tracellular stimulation, (2) increased seizure susceptibility to challenges 
with chemo-convulsants (e.g., kainic acid and flurothyl), and (3) brief 
(i.e., <15 seconds) rhythmic activity in the EEG. Although each of these 
changes could be interpreted as being pro-excitatory and, by extension, 
pro-epileptogenic, the actual basis for each of these changes and their im-
plications for the development of epilepsy are poorly understood. This 
workshop will debate the pros and cons of these different surrogate mark-
ers, which are often used to validate animal models of acquired epilepsy, 
to test hypotheses about mechanisms of epileptogensis, and ultimately, to 
discover anti-epileptogenic therapies. We will present opposing positions, 
and invite the audience to comment on the potential utility and predictive 
value of each of the markers.
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